Donald S. Baim, M.D., is Executive Vice President, Chief Medical and Scientific Officer at Boston Scientific Corporation as of July 3, 2006. Before joining Boston Scientific, Dr. Baim was a Professor of Medicine at Harvard Medical School, Senior Physician at the Brigham and Women's Hospital, and an internationally recognized leader in interventional cardiology who specialized in the development and evaluation of new interventional cardiovascular devices. He has published nearly 300 scientific papers on interventional cardiology, edited the leading textbook in the field (Grossman's Cardiac Catheterization, Angiography and Intervention, now in its 7th edition), and has served as a member of the Interventional Cardiology Test Committee of the American Board of Internal Medicine (ABIM). Dr. Baim has been the national Principal Investigator on literally dozens of clinical trials in interventional cardiology, and a founder or key consultant for more than 20 start-up companies and medical device incubators in areas ranging from embolic protection, thrombectomy, chronic total occlusions, arterial closure, novel stent and coatings, heart failure, and percutaneous heart valves. He was the recipient of the Career Achievement Award at TCT 2000, based on his clinical, research, and educational contributions to the field. Dr. Baim completed his undergraduate training in Physics at the University of Chicago, and then received a M.D. from Yale University School of Medicine. During post-graduate training in medicine and cardiology at Stanford, he worked with Dr. John Simpson during the development of some of the earliest moveable guidewire coronary angioplasty catheters. In 1981, Dr. Baim was recruited to establish an Interventional Cardiology program at Boston's Beth Israel Hospital. Under his leadership, this program went on to perform seminal research in the refinement, critical evaluation and optimal application of newer devices, including stents, atherectomy, clot removal and distal embolic protection. In 2000, he was recruited by the Brigham and Women's Hospital in Boston, where in addition to his clinical responsibilities, he directed the hospital's participation in the Center for the Integration of Medicine and Innovative Technology (CIMIT), a federally funded inter-disciplinary consortium of leading Boston teaching hospitals and engineering institutions that develops innovative device solutions for a wide range of unmet medical challenges. Since 2005, Dr. Baim has also served as Chief Academic Officer of the Harvard Clinical Research Institute (HCRI), a not-for-profit organization that designs, conducts, and analyzes pilot and pivotal trials of new medical devices to support their approval by the U.S. Food and Drug Administration (FDA).
